These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 33038669
1. Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma. Boonzaier NR, Hales PW, D'Arco F, Walters BC, Kaur R, Mankad K, Cooper J, Liasis A, Smith V, O'Hare P, Hargrave D, Clark CA. Neuroimage Clin; 2020; 28():102447. PubMed ID: 33038669 [Abstract] [Full Text] [Related]
2. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort. Falzon K, Drimtzias E, Picton S, Simmons I. Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527 [Abstract] [Full Text] [Related]
3. Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas. Arnljots U, Nilsson M, Bolzani R, Benassi M, Sandvik U, Munoz DM, Blomgren K, Hellgren K. PLoS One; 2024 Oct; 19(7):e0305548. PubMed ID: 38990917 [Abstract] [Full Text] [Related]
4. Delineation of the visual pathway in paediatric optic pathway glioma patients using probabilistic tractography, and correlations with visual acuity. Hales PW, Smith V, Dhanoa-Hayre D, O'Hare P, Mankad K, d'Arco F, Cooper J, Kaur R, Phipps K, Bowman R, Hargrave D, Clark C. Neuroimage Clin; 2018 Oct; 17():541-548. PubMed ID: 29527480 [Abstract] [Full Text] [Related]
5. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature. Friedrich RE, Nuding MA. Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519 [Abstract] [Full Text] [Related]
6. Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma. Brossier NM, Thondapu S, Cobb OM, Dahiya S, Gutmann DH. Neuro Oncol; 2021 Apr 12; 23(4):625-637. PubMed ID: 33080011 [Abstract] [Full Text] [Related]
13. The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital. Rony C, Aharoni S, Halevy A. Neuropediatrics; 2022 Oct 12; 53(5):370-375. PubMed ID: 35381604 [Abstract] [Full Text] [Related]
14. Investigation of retinal nerve fiber layer thickness and ganglion cell layer-inner plexiform layer thickness in patients with optic pathway gliomas. Hepokur M, Sarici AM. Graefes Arch Clin Exp Ophthalmol; 2018 Sep 12; 256(9):1757-1765. PubMed ID: 29754292 [Abstract] [Full Text] [Related]
15. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. Levin MH, Armstrong GT, Broad JH, Zimmerman R, Bilaniuk LT, Feygin T, Li Y, Liu GT, Fisher MJ. Br J Ophthalmol; 2016 Apr 12; 100(4):510-4. PubMed ID: 26294105 [Abstract] [Full Text] [Related]
16. Tumor load rather than contrast enhancement is associated with the visual function of children and adolescents with optic pathway glioma - a retrospective Magnetic Resonance Imaging study. Kilian A, Aigner A, Simon M, Salchow DJ, Potratz C, Thomale UW, Hernáiz Driever P, Tietze A. J Neurooncol; 2022 Feb 12; 156(3):589-597. PubMed ID: 34994964 [Abstract] [Full Text] [Related]
18. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1. de Blank PM, Berman JI, Liu GT, Roberts TP, Fisher MJ. Neuro Oncol; 2013 Aug 12; 15(8):1088-95. PubMed ID: 23658320 [Abstract] [Full Text] [Related]
20. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1. Trevisson E, Cassina M, Opocher E, Vicenzi V, Lucchetta M, Parrozzani R, Miglionico G, Mardari R, Viscardi E, Midena E, Clementi M. J Neurooncol; 2017 Sep 12; 134(2):279-287. PubMed ID: 28577031 [Abstract] [Full Text] [Related] Page: [Next] [New Search]